Ewopharma is launching the orphan drug Raxone
Ewopharma is strengthening its orphan business and has signed an agreement with Santhera to launch Raxone for the treatment of Leber's Hereditary Optic Neuropathy (LHON) in …
Ewopharma is complementing its portfolio with innovative phytotherapy products
Ewopharma is extending its portfolio of herbal drugs with several evidence-based products. The new products complement Ewopharma’s offer in gastroenterology, pediatrics and …
Ewopharma introduces a new therapy for late-stage Parkinson patients
A new therapy for late-stage Parkinson patients, who cannot be effectively treated using oral anti-Parkinson medicine, is introduced by Ewopharma. Dacepton (apomorphine …
Ewopharma extends its ENT portfolio
Ewopharma is launching two new ENT products. The first one is for the treatment of acute otitis externa and the second one helps to prevent it.
Acute otitis externa is an …
Ewopharma takes over responsibility for meningitis C vaccine
Ewopharma AG is pleased to announce its cooperation with Nuron Biotech, an innovative US company focused on vaccines and specialty biologics for the prevention and treatment of …
Ewopharma is expanding its local presence in Central Eastern Europe
With the recent establishment of the new Ewopharma Representative Office in Skopje, Macedonia, the Ewopharma Group has made another important step in the implementation of its …
Ewopharma strengthens its OTC business with two strong German phytomedicine products
Ewopharma signed a cooperation agreement with two independent medium sized companies from Germany: Schwabe Pharmaceuticals and Krewel Meuselbach. Their well-documented plant-based …
Ewopharma launches state-of-the-art iron therapy from Pharmacosmos
Ewopharma entered into a new partnership with Pharmacosmos, a leading specialist in intravenous iron therapy with innovative pharmaceutical products to replenish body iron stores …
New cooperation with Aptalis further strengthens gastroenterology portfolio
Ewopharma AG is pleased to announce its cooperation with Aptalis Pharma, a leading international specialty pharmaceutical company with headquarters in Canada and focus on cystic …
Entering new markets with Perskindol®.
Following its success with Perskindol in Slovenia, Ewopharma is now about to launch the product range also in other markets. Perskindol, the natural product line used for the …
Ewopharma AG acquires Newport Pharmaceuticals Ltd.
Schaffhausen, Switzerland, Oct 20, 2011 – Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to announce its …
New cooperation with Spirig Pharma AG
Ewopharma AG is pleased to announce its new cooperation with Spirig Pharma AG, an independent Swiss dermatology specialist. Spirig is clear market leader in dermatology in …
Launch of BioGaia Prodentis
Ewopharma is pleased to announce the launch of BioGaia Prodentis in Slovakia and Bulgaria.
With the Prodentis lozenges, Ewopharma completes the successful range of probiotic …
New Country Manager in Poland
Arkadiusz Malewicz, Master of Pharmacy, has started in his new engagement for Ewopharma in May, 2011.
Our new homepage is online!
Ewopharma’s new homepage is online as of today. Its new design and user-friendly structure shall allow visitors to manoeuvre more easily and with more pleasure through “EWOland”.